The MVP-5 system is used to reduce or obstruct blood flow for vessels between 3 and 5 mm in the peripheral vasculature.
More Articles on FDA Approvals:
FDA Approves Second Drug in Two Weeks to Treat Hepatitis C
4 Latest FDA Approvals
FDA Approves Linzess for Irritable Bowel Syndrome and Constipation
